News Conference News EuroPCR 2018 Two Sham-Controlled Renal Denervation Studies Offer Hope in Hypertension By Michael O'Riordan May 23, 2018
News Conference News EuroPCR 2018 Modest Benefit of PCI Over Medical Therapy in Patients With ‘Grey Zone’ FFR Lesions By Michael O'Riordan May 23, 2018
News Conference News EuroPCR 2018 ‘Almost Perfect’ Agreement Seen Between Angiography- and CTA-Guided Treatment Decisions in Left Main, Three-Vessel Disease By Yael L. Maxwell May 22, 2018
News Conference News EuroPCR 2018 FFR-Guided PCI Reduces Risk of Death/MI Compared With Medical Therapy: Pooled Analysis By Michael O'Riordan May 22, 2018
News Conference News EuroPCR 2018 FFR in PCI for Stable CAD: Lasting Benefit Shown by FAME 2, SCAAR Data By Caitlin E. Cox May 22, 2018
News Conference News EuroPCR 2018 New ORBITA Insights: Invasive Physiology Tests Track Closely With Ischemia, but Not Symptom Improvement By Shelley Wood May 22, 2018
News Conference News EuroPCR 2018 Big Data, Big Questions: Physicians and Innovators Consider AI’s Role in Clinical Care By Michael O'Riordan May 21, 2018
News Conference News HRS 2018 ‘Think Big, But Act Small’: Specialized A-fib Clinic Cuts Mortality By Todd Neale May 18, 2018
News Conference News EuroPCR 2018 EuroPCR 2018: Stable CAD, Functional Tests, and Renal Denervation Take Center Stage By Shelley Wood May 17, 2018
News Conference News HRS 2018 HRS: Here’s How to Talk About Cybersecurity Concerns and Implantable Devices By Todd Neale May 17, 2018